“…As with GABA receptors, lesions of the neostriatum lead to a decrease in benzodiazepine binding in that area (Sperk and Schlogl, 1979;Chang et al, 1980); however, whereas these lesions result in an increase in GABA binding sites in the substantia nigra Waddington and Cross, 1980), benzodiazepine binding is decreased in affinity (Biggio et al, 1979), although the sensitivity to enhancement by GABA (discussed below) was increased (Shibuya et a]., 1980). Lesions of the cerebellum (Chang et al, 1980;Biggio et al, 1980;Speth et al, 1981) and mutants depleted in certain types of cerebellar cells (Lippa et al, 1978;Skolnick et al, 1979;Speth et al, 1981) demonstrate that the majority of detectable GABA receptor sites are localized to granule cells without apparent correspondence of benzodiazepine binding sites, which are proportionally more dense on Purkinje cells. Whether benzodiazepine receptors are found in any cells or membrane locations iacking GABA receptors remains in question.…”